LinkedIn
ALOOSTA
Contact
The validity period for the approval for 13 active substances has been extended by one year due to the delay in the re-evaluation following the application for renewal of the approval. We list the organic active ingredients only.
Wir beschränken uns in der Darstellung auf die chemischen Wirkstoffe.
|
Active ingredients |
limited until |
Reference |
|
Benzovindiflupyr |
02.08.2026 |
1) |
|
Bromuconazole |
30.04.2027 |
|
|
Buprofezin |
15.12.2025 |
|
|
Cyflufenamid |
30.06.2027 |
|
|
Fluazinam |
15.04.2026 |
|
|
Fluopyram |
30.06.2026 |
|
|
Flutolanil |
16.06.2025 |
|
|
Lambda-Cyhalothrin |
31.08.2026 |
|
|
Mecoprop-P |
15.05.2025 |
|
|
Mepiquat |
15.10.2025 |
|
|
Metsulfuron-methyl |
31.08.2026 |
|
|
Phosphane |
15.03.2026 |
|
|
Pyraclostrobin |
15.09.2025 |
If the review for any of the active ingredients leads to rejection of the renewal application in the meantime, the approval will expire with a corresponding order ahead of schedule.
The lifetime extensions have no influence on the current maximum residue limits.
Author: Dr. Frank Mörsberger
Contact
Career